News
Zacks Small Cap Research on MSN49m
LTRN: IND Clearance for LP-184 in TNBCLTRN A May 5th press release indicated that the FDA cleared Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-184 trial in triple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback